Articles from The Motley Fool

HCA earnings call for the period ending December 31, 2024.

EBC earnings call for the period ending December 31, 2024.

VZ earnings call for the period ending December 31, 2024.

The clean energy stock could climb even higher in 2025.

AXP earnings call for the period ending December 31, 2024.

ERIC earnings call for the period ending December 31, 2024.

NEE earnings call for the period ending December 31, 2024.

Novo Nordisk may have found a winner in amycretin.

After finally meeting the market in 2024, the House of Mouse is ready to beat the market in 2025.

NextEra Energy reported mixed earnings for Q4 2024, meeting EPS expectations but missing on revenue.

SK Hynix continues to see strong demand for HBM solutions thanks to AI accelerators.

Nvidia stock investors can benefit from the recent AI updates.

HCA Healthcare reported solid revenue growth in Q4, but faced challenges, missing its earnings per share estimates due to hurricane impacts.

Verizon Communications reported solid fourth-quarter earnings driven by robust wireless service revenue growth and strong free cash flow.

Many quantum computing stocks have risen well above Wall Street's price targets, but this one still has room to climb.

American Express posted record Q4 revenue and earnings while also beating analysts' expectations.

It may be more of a struggle than expected.

Looking for the next big thing in AI and tech stocks? Check out why one supporting player might be a better pick than the usual household name.

Wolfspeed continues to burn cash as it invests in improving its manufacturing capabilities, which could be a massive growth driver.

This sleepy REIT faces tougher near-term challenges than its industry peers.

Wall Street's bulls expect the card processor's stock to head even higher.

XRP has skyrocketed recently, but how much higher can it soar? Here's what you need to know.

Although AbbVie has lost patent exclusivity for its flagship drug, Humira, the company may soon be bigger and better.